Header Logo

Connection

Charles Feldman to Pneumonia

Back to Details
This is a "connection" page, showing publications Charles Feldman has written about Pneumonia.
Charles Feldman
Connection Strength
7,239
Pneumonia
  1. Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia. Clin Chest Med. 2025 Mar; 46(1):93-104.
    View in: PubMed
    Score: 0,853
  2. Severe community-acquired pneumonia at a tertiary academic hospital in Johannesburg, South Africa. Respir Med. 2024 Nov-Dec; 234:107823.
    View in: PubMed
    Score: 0,846
  3. Community-Acquired Pneumonia: A Global Perspective. Semin Respir Crit Care Med. 2020 Aug; 41(4):453-454.
    View in: PubMed
    Score: 0,630
  4. Pneumonia as a systemic illness. Curr Opin Pulm Med. 2018 05; 24(3):237-243.
    View in: PubMed
    Score: 0,542
  5. Community-Acquired Pneumonia: A Global Perspective. Semin Respir Crit Care Med. 2016 12; 37(6):797-798.
    View in: PubMed
    Score: 0,492
  6. Community-acquired pneumonia: still a major burden of disease. Curr Opin Crit Care. 2016 10; 22(5):477-84.
    View in: PubMed
    Score: 0,486
  7. Response. Chest. 2016 Feb; 149(2):603-604.
    View in: PubMed
    Score: 0,464
  8. Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies. Chest. 2015 Aug; 148(2):523-532.
    View in: PubMed
    Score: 0,448
  9. Pneumonia associated with HIV infection. Curr Opin Infect Dis. 2005 Apr; 18(2):165-70.
    View in: PubMed
    Score: 0,219
  10. Pneumonia in the elderly. Med Clin North Am. 2001 Nov; 85(6):1441-59.
    View in: PubMed
    Score: 0,173
  11. Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2021 07; 18(7):1087-1097.
    View in: PubMed
    Score: 0,169
  12. An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia. Int J Antimicrob Agents. 2001 Mar; 17(3):177-88.
    View in: PubMed
    Score: 0,165
  13. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa. Int J Antimicrob Agents. 2020 Dec; 56(6):106189.
    View in: PubMed
    Score: 0,160
  14. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel. Chest. 2020 11; 158(5):1912-1918.
    View in: PubMed
    Score: 0,159
  15. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest. 2020 11; 158(5):1896-1911.
    View in: PubMed
    Score: 0,157
  16. Pneumonia in the elderly. Clin Chest Med. 1999 Sep; 20(3):563-73.
    View in: PubMed
    Score: 0,149
  17. Epidemiology of lower respiratory tract infections in adults. Expert Rev Respir Med. 2019 01; 13(1):63-77.
    View in: PubMed
    Score: 0,142
  18. Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia. Respirology. 2017 07; 22(5):845-846.
    View in: PubMed
    Score: 0,125
  19. Severe community-acquired pneumonia. Curr Opin Pulm Med. 1997 Mar; 3(2):98-104.
    View in: PubMed
    Score: 0,125
  20. IgG subclasses in previously healthy adult patients with acute community-acquired pneumonia. S Afr Med J. 1996 May; 86(5 Suppl):600-2.
    View in: PubMed
    Score: 0,118
  21. Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit. Respir Med. 2015 Jun; 109(6):743-50.
    View in: PubMed
    Score: 0,110
  22. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med. 1995 Mar; 89(3):187-92.
    View in: PubMed
    Score: 0,109
  23. The continuing problem of community-acquired bacterial pneumonia. S Afr Med J. 1992 Feb 01; 81(3):129-31.
    View in: PubMed
    Score: 0,088
  24. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011 Jan-Feb; 26(1):34-40.
    View in: PubMed
    Score: 0,082
  25. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. Clin Microbiol Infect. 2007 Feb; 13(2):162-171.
    View in: PubMed
    Score: 0,062
  26. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2006 Jul; 10(7):739-43.
    View in: PubMed
    Score: 0,060
  27. Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J. 2006 Jan; 27(1):9-11.
    View in: PubMed
    Score: 0,058
  28. Patterns of cytokine expression in community-acquired pneumonia. Chest. 1995 May; 107(5):1342-9.
    View in: PubMed
    Score: 0,028
  29. Does primary Streptococcus viridans pneumonia exist? S Afr Med J. 1992 Dec; 82(6):432-4.
    View in: PubMed
    Score: 0,023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.